185 related articles for article (PubMed ID: 32593527)
1. Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohort.
Percot M; Robert G; Bladou F; Ferrière JM; Bensadoun H; Bernhard JC; Alezra E; Capon G; Sénéchal C; Gourtaud G; Brureau L; Roux V; Blanchet P; Eyraud R
Prog Urol; 2020 Sep; 30(10):532-540. PubMed ID: 32593527
[TBL] [Abstract][Full Text] [Related]
2. Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre.
Kum F; Beckmann K; Aya H; Singh S; Sandhu P; Sra S; Rusere J; Zisengwe G; Santaolalla A; Cathcart P; Challacombe B; Brown C; Popert R; Dasgupta P; Van Hemelrijck M; Elhage O
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):549-557. PubMed ID: 33558659
[TBL] [Abstract][Full Text] [Related]
3. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
Brureau L; Emeville E; Multigner L; Blanchet P
Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance for Favorable Risk Prostate Cancer in African Caribbean Men: Results of a Prospective Study.
Meunier ME; Eyraud R; Sénéchal C; Gourtaud G; Roux V; Lanchon C; Brureau L; Blanchet P
J Urol; 2017 May; 197(5):1229-1236. PubMed ID: 27993665
[TBL] [Abstract][Full Text] [Related]
5. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
6. Overall, specific, and metastasis-free survival of Afro-Caribbean men with pathological Gleason 6 prostate cancer.
Mollard P; Perrot E; Blanchet P; Brureau L
Prostate; 2020 Mar; 80(4):329-335. PubMed ID: 31868959
[TBL] [Abstract][Full Text] [Related]
7. [The significance of PSA density as predictive factor in Afro-Caribbean patients eligible for active surveillance by the French protocol criteria].
Loiselle A; Senechal C; Nevoux P; Benazzouz H; Bhakkan-Mambir B; Casenave J; Gourtaud G; Fofana M; Blanchet P
Prog Urol; 2014 May; 24(6):327-33. PubMed ID: 24821554
[TBL] [Abstract][Full Text] [Related]
8. [Stage IV prostate cancer in Guadeloupe, a French Caribbean archipelago].
Casenave J; Sénéchal C; Nevoux P; Gourtaud G; Tressières B; Blanchet P
Prog Urol; 2014 Mar; 24(3):167-72. PubMed ID: 24560205
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and progression-free survival of Afro-Caribbean men with metastatic hormone-sensitive prostate cancer at the time of diagnosis.
Rossignol T; Gourtaud G; Senechal C; Sadreux Y; Roux V; Blanchet P; Brureau L
Prostate; 2021 Oct; 81(14):1091-1096. PubMed ID: 34320690
[TBL] [Abstract][Full Text] [Related]
10. Grade groups at diagnosis in African Caribbean men with prostate cancer: Results of a comparative study.
Meunier ME; Tantot J; Neuzillet Y; Ghoneim TP; Martin F; Taouil T; Vignac M; Baumert H; Vinh-Hung V; Dussaule-Duchatelle V; Lebret T; Sutter W; Molinié V
Prostate; 2019 Oct; 79(14):1640-1646. PubMed ID: 31376218
[TBL] [Abstract][Full Text] [Related]
11. [Salvage radiotherapy outcomes for biochemical recurrence following radical prostatectomy among the African-Caribbean population of Guadeloupe].
Agoua NG; Vian E; Dumoulin M; Blanchet P
Prog Urol; 2013 Feb; 23(2):128-36. PubMed ID: 23352306
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma in the Afro-Caribbean community: an 11-year retrospective study.
Cordel N; Bonnecarrère L; Tressières B
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1462-1467. PubMed ID: 28543620
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
14. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
Deka R; Courtney PT; Parsons JK; Nelson TJ; Nalawade V; Luterstein E; Cherry DR; Simpson DR; Mundt AJ; Murphy JD; D'Amico AV; Kane CJ; Martinez ME; Rose BS
JAMA; 2020 Nov; 324(17):1747-1754. PubMed ID: 33141207
[TBL] [Abstract][Full Text] [Related]
15. Biopsy Grade Group as a reliable prognostic factor for BCR in Afro-Caribbean men with intermediate- and high-risk prostate cancer.
Perrot E; Seddik S; Gourtaud G; Eyraud R; Roux V; Moureaux C; Blanchet P; Brureau L
World J Urol; 2020 Jun; 38(6):1493-1499. PubMed ID: 31485740
[TBL] [Abstract][Full Text] [Related]
16. Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database.
Shah S; Beckmann K; Van Hemelrijck M; Challacombe B; Popert R; Dasgupta P; Rusere J; Zisengwe G; Elhage O; Santaolalla A
BMC Cancer; 2021 May; 21(1):573. PubMed ID: 34011308
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and prostate cancer in Afro-Caribbean men.
Lefebvre F; Blanchet-Deverly A; Michineau L; Blanchet P; Multigner L; Brureau L
Prostate; 2022 Feb; 82(3):359-365. PubMed ID: 34905623
[TBL] [Abstract][Full Text] [Related]
18. Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer.
Nyame YA; Wilkins L; Greene DJ; Ganesan V; Dai C; Almassi N; Stephenson AJ; Gong M; Berglund R; Klein EA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):617-623. PubMed ID: 30996285
[TBL] [Abstract][Full Text] [Related]
19. The role of inheritance and environment in predisposition to vascular disease in people of African descent.
Kalra L; Rambaran C; Iveson E; Chowienczyk PJ; Hambleton I; Ritter JM; Shah A; Wilks R; Forrester T
J Am Coll Cardiol; 2006 Mar; 47(6):1126-33. PubMed ID: 16545641
[TBL] [Abstract][Full Text] [Related]
20. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years.
Salari K; Kuppermann D; Preston MA; Dahl DM; Barrisford GW; Efstathiou JA; Blute ML; Vesprini D; Loblaw A; Zietman AL; Klotz L; Feldman AS
J Urol; 2019 Apr; 201(4):721-727. PubMed ID: 30664083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
